Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women
Launched by MEDICAL UNIVERSITY OF LUBLIN · Nov 5, 2020
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
Purpose The King's Health Questionnaire (KHQ) and the International Consultation on Incontinence Modular Questionnaire (ICIQ-SF) Short Form are widely used in clinical practice. The aim of this study was to assess the psychometric properties of KHQ and ICIQ-SF in polish women.
Methods One hundred fifty-five women with urinary incontinence (UI) aged between 19-82 years underwent urodynamic investigation and completed both KHQ and ICIQ-SF. To evaluate the factor structure and construct the validity of the KHQ and ICIQ, Principal Component Analysis (PCA) using VARIMAX rotation was conducted f...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • informed consent
- • patients with symptoms of urinary incontinence
- • age 18-82 years
- Exclusion Criteria:
- • lack of consent
- • inability to understand the study protocol
About Medical University Of Lublin
The Medical University of Lublin is a distinguished academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a vibrant environment for medical and scientific inquiry, aiming to improve patient outcomes and contribute to the broader medical community. Its commitment to ethical research practices and patient safety ensures that all clinical trials conducted under its auspices adhere to the highest standards of scientific rigor and regulatory compliance. The Medical University of Lublin is positioned at the forefront of medical education and research in Poland, making significant contributions to the fields of medicine, pharmacy, and health sciences.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lublin, , Poland
Patients applied
Trial Officials
Tomasz Rechberger, Professor
Study Director
Medical University of Lublin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials